scholarly article | Q13442814 |
P2093 | author name string | D B Rifkin | |
F G Giancotti | |||
J G Harpel | |||
J S Munger | |||
P2860 | cites work | Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta | Q24321274 |
Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence | Q24564411 | ||
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein | Q24673676 | ||
Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism | Q24674746 | ||
Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta | Q24683923 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
Latent transforming growth factor-beta: structural features and mechanisms of activation | Q28238140 | ||
Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor | Q28250273 | ||
The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line | Q28257562 | ||
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils | Q28286838 | ||
Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility | Q28286870 | ||
A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5 | Q28291862 | ||
Negative regulation of transforming growth factor-beta by the proteoglycan decorin | Q28292224 | ||
Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity | Q28304357 | ||
A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1) | Q28306823 | ||
The alpha v beta 1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin | Q28644401 | ||
The transforming growth factor-beta family | Q29615948 | ||
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 | ||
The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression | Q34197959 | ||
Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor | Q34686171 | ||
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. | Q34733220 | ||
Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization | Q36221243 | ||
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells | Q36383054 | ||
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells | Q36383154 | ||
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors | Q36405679 | ||
Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells | Q37375977 | ||
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor | Q37376979 | ||
Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. | Q38290911 | ||
alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells | Q38615044 | ||
Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide | Q41256244 | ||
Integrin signaling: specificity and control of cell survival and cell cycle progression | Q41612555 | ||
Calcium as a potential physiological regulator of integrin-mediated cell adhesion | Q41691588 | ||
Arginine-glycine-aspartic acid adhesion receptors | Q41786100 | ||
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix | Q43755354 | ||
Regulation of the fibronectin receptor affinity by divalent cations. | Q44461951 | ||
Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands. | Q54558054 | ||
Cell adhesion protein receptors as targets for transforming growth factor-beta action | Q68830658 | ||
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes | Q71604126 | ||
Protection of transforming growth factor-beta 1 activity by heparin and fucoidan | Q71615229 | ||
Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin | Q71803700 | ||
Biochemical characterization of human osteoclast integrins. Osteoclasts express alpha v beta 3, alpha 2 beta 1, and alpha v beta 1 integrins | Q72865482 | ||
Growth factors in the extracellular matrix | Q73075408 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2627-38 | |
P577 | publication date | 1998-09-01 | |
P1433 | published in | Molecular Biology of the Cell | Q2338259 |
P1476 | title | Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1 | |
P478 | volume | 9 |
Q55362406 | A Context-Dependent Role for αv Integrins in Regulatory T Cell Accumulation at Sites of Inflammation. |
Q24292398 | ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo |
Q36117987 | Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice |
Q46739165 | Activation of TGF-beta1 through up-regulation of TSP-1 by retinoic acid in retinal pigment epithelial cells |
Q34265512 | An examination of the proteolytic activity for bovine pregnancy-associated glycoproteins 2 and 12. |
Q40490472 | Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway |
Q91879175 | BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics |
Q36646138 | Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells |
Q34094906 | Biomarkers of acute lung injury: worth their salt? |
Q54491839 | Biophysical comparison of BMP-2, ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature growth factor. |
Q77922259 | Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins |
Q37106657 | Choreographing metastasis to the tune of LTBP. |
Q46794933 | Consequences of epithelial or stromal TGFβ1 depletion in the mammary gland |
Q36950562 | Controversy surrounding the increased expression of TGF beta 1 in asthma |
Q37928833 | Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix |
Q90752446 | Customizable biomaterials as tools for advanced anti-angiogenic drug discovery |
Q26745695 | Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression |
Q28394607 | Cyclical strain modulates metalloprotease and matrix gene expression in human tenocytes via activation of TGFβ |
Q37550644 | Defining the role of integrin alphavbeta6 in cancer |
Q38580461 | Dissecting fibrosis: therapeutic insights from the small-molecule toolbox |
Q100490624 | Emerging role of tumor cell plasticity in modifying therapeutic response |
Q48336271 | Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro |
Q41670915 | Exploring the Role of RGD-Recognizing Integrins in Cancer |
Q34075918 | Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion |
Q36489766 | Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey |
Q37189687 | Extracellular matrix-induced gene expression in human breast cancer cells |
Q44412857 | Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation |
Q42831541 | Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes |
Q35063558 | Gene transcriptional networks integrate microenvironmental signals in human breast cancer |
Q43163564 | Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes |
Q36767882 | Identification and association of TGFβ-1 expression in patients with asthma in a Polish population - Lodz metropolitan area study |
Q33492753 | In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-beta1. |
Q37469875 | Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide |
Q38622506 | Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts |
Q36512337 | Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production. |
Q40545957 | Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. |
Q36322417 | Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. |
Q39682189 | Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus |
Q24685525 | Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue |
Q92784010 | Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment |
Q35221935 | Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit |
Q37362030 | Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders |
Q38219401 | Integrins and cadherins as therapeutic targets in fibrosis |
Q38631821 | Integrins and integrin-related proteins in cardiac fibrosis |
Q28066805 | Integrins in the Spotlight of Cancer |
Q37590219 | Interplay between cell adhesion and growth factor receptors: from the plasma membrane to the endosomes |
Q45893509 | It has to be the αv: myofibroblast integrins activate latent TGF-β1. |
Q33327079 | Latency associated peptide has in vitro and in vivo immune effects independent of TGF-beta1 |
Q35861493 | Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation |
Q50289818 | Latent TGF-beta-1 binds integrins |
Q34193054 | Latent Transforming Growth Factor-β-binding Protein 2 Is an Adhesion Protein for Melanoma Cells |
Q34619626 | Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. |
Q27002535 | Matrix control of transforming growth factor-β function |
Q38127775 | Matrix mechanics and regulation of the fibroblast phenotype |
Q38166449 | Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes |
Q36909821 | Methods for identifying novel integrin ligands |
Q42563021 | Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice |
Q39364702 | Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. |
Q34078150 | Mouse models of genetic diseases resulting from mutations in elastic fiber proteins |
Q35234874 | Mutations in a TGF-β ligand, TGFB3, cause syndromic aortic aneurysms and dissections |
Q24678290 | Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix |
Q34382264 | Overexpression of TGF-ß 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ß. |
Q34632691 | Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules |
Q24795499 | RETRACTED: TGFβ1 signaling via αVβ6 integrin |
Q28077930 | Reactive oxygen species and fibrosis: further evidence of a significant liaison |
Q26786129 | Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences |
Q33583361 | Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver |
Q36472048 | Regulation of fibrosis by the immune system |
Q39623677 | Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes |
Q38851167 | Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins |
Q92384293 | Regulatory cytokine function in the respiratory tract |
Q24635194 | Review of the activation of TGF-beta in immunity |
Q55437873 | Role of integrin alpha8 in murine model of lung fibrosis. |
Q35550776 | SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity |
Q35125022 | Selective targeting of TGF-β activation to treat fibroinflammatory airway disease |
Q90150506 | Structural insights into conformational switching in latency-associated peptide between transforming growth factor β-1 bound and unbound states |
Q35639996 | TGF-beta signaling in human skeletal and patterning disorders |
Q39155183 | TGF-β Family Signaling in Connective Tissue and Skeletal Diseases |
Q33566661 | TGF-β activation and function in immunity |
Q35864472 | TGF-β-Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease. |
Q41106710 | TGF-β1 autocrine signalling and enamel matrix components |
Q36694167 | TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy. |
Q60922525 | TGFβ, smooth muscle cells and coronary artery disease: a review |
Q104795035 | Targeting TGFβ signal transduction for cancer therapy |
Q33760068 | Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis |
Q62697773 | Targeting cytokines to inflammation sites |
Q36580090 | Targeting integrin structure and function in disease |
Q37374921 | Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs |
Q51763444 | The dynamics of TGF-β in dental pulp, odontoblasts and dentin. |
Q28137622 | The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis |
Q24673453 | The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1 |
Q40753504 | The integrin alphaVbeta6 binds and activates latent TGFbeta3. |
Q24535009 | The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3 |
Q34784557 | The latent transforming growth factor-beta-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium |
Q35577299 | The metastatic tumor antigen 1-transglutaminase-2 pathway is involved in self-limitation of monosodium urate crystal-induced inflammation by upregulating TGF-β1 |
Q43984586 | The selective regulation of alpha Vbeta 1 integrin expression is based on the hierarchical formation of alpha V-containing heterodimers |
Q35703159 | The αvβ1 integrin plays a critical in vivo role in tissue fibrosis |
Q64265684 | Transformation of the Transcriptomic Profile of Mouse Periocular Mesenchyme During Formation of the Embryonic Cornea |
Q39010776 | Transforming Growth Factor β1 Function in Airway Remodeling and Hyperresponsiveness. The Missing Link? |
Q35860853 | Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter. |
Q35792147 | Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice |
Q55423261 | Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer. |
Q35172753 | Transforming growth factor-beta and its role in asthma |
Q34438032 | Transforming growth factor-beta signal transduction in epithelial cells. |
Q47102060 | Two functional domains in C. elegans glypican LON-2 can independently inhibit BMP-like signaling |
Q37192207 | Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation |
Q37260433 | beta8 integrins are required for vascular morphogenesis in mouse embryos |
Q36902380 | α-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFβ activation or collagen production across multiple models of organ fibrosis |
Q53620505 | α5 and αv integrins cooperate to regulate vascular smooth muscle and neural crest functions in vivo. |
Q35524640 | αVβ6 integrin promotes corneal wound healing |
Q34360208 | αv Integrin expression by DCs is required for Th17 cell differentiation and development of experimental autoimmune encephalomyelitis in mice |
Q37410984 | αvβ1 integrin as a novel therapeutic target for tissue fibrosis |
Search more.